Selected article for: "rapid diagnosis and treatment rapid diagnosis"
Author: Lim, Jun Hyeok; Ryu, Jeong-Seon; Cho, Sang Yong; Kim, Hyun-Jung; Jeon, Sang Hoon; Kim, Jung Soo; Nam, Hae-Seong; Cho, Jae Hwa; Kwak, Seung Min; Lee, Hong Lyeol
Title: Small-cell Lung Cancer Presenting as Fatal Pulmonary Hemorrhage
  • Document date: 2018_3_21
    • ID: r69j2tnw_9
    Snippet: To our knowledge, this is the first report describing an SCLC patient presenting with fatal pulmonary hemorrhage due to refractory thrombocytopenia. SCLC is the most aggressive histological subtype of lung cancer. However, favorable response is expected in 60% to 70% of patients with extensive-stage disease when systemic chemotherapy is given [3, 4] . Life-threatening manifestations rarely present in SCLC patients. When such manifestations do app.....
    Document: To our knowledge, this is the first report describing an SCLC patient presenting with fatal pulmonary hemorrhage due to refractory thrombocytopenia. SCLC is the most aggressive histological subtype of lung cancer. However, favorable response is expected in 60% to 70% of patients with extensive-stage disease when systemic chemotherapy is given [3, 4] . Life-threatening manifestations rarely present in SCLC patients. When such manifestations do appear, as in the present case, the rapid-onset, unusual presentation may delay diagnosis or hesitation in deciding treatment, affecting survival adversely [7] . Therefore, prompt diagnosis and treatment is a critical issue [8] .

    Search related documents:
    Co phrase search for related documents
    • adversely survival affect and survival affect: 1, 2, 3, 4
    • critical issue and lung cancer: 1
    • extensive stage and lung cancer: 1, 2, 3, 4, 5, 6, 7
    • extensive stage disease and lung cancer: 1
    • fatal pulmonary hemorrhage and lung cancer: 1
    • fatal pulmonary hemorrhage and pulmonary hemorrhage: 1, 2
    • fatal pulmonary hemorrhage and rapid onset: 1
    • fatal pulmonary hemorrhage and refractory thrombocytopenia: 1
    • fatal pulmonary hemorrhage and SCLC patient: 1
    • favorable response and histological subtype: 1
    • favorable response and lung cancer: 1
    • favorable response and lung cancer histological subtype: 1
    • favorable response and present case: 1, 2, 3, 4
    • favorable response and rapid onset: 1
    • favorable response and refractory thrombocytopenia: 1
    • favorable response and unusual presentation: 1